29 de noviembre de 2020, 0:33
Mexico, Nov 29 (Prensa Latina) Mexico has bought in advance more than 200 million doses of different vaccines against Covid-19, with which it intends to cover 92 percent of its population, the Foreign Affairs Ministry has confirmed.
Mexico, Nov 29 (Prensa Latina) Mexico has bought in advance more than 200 million doses of different vaccines against Covid-19, with which it intends to cover 92 percent of its population, the Foreign Affairs Ministry has confirmed.
In a press release, the Undersecretary of Multilateral Affairs and Human Rights, Martha Delgado, refuted with those figures the data issued by the World Economic Fund (WEF), which leaves Mexico out of the countries that have purchased more vaccines against Covid-19.
WEF stressed that each vaccine needs two doses to generate protection against the disease and added that only Canada, Japan, the United States and the United Kingdom would be the only governments capable of vaccinating more than 100 percent of their population.
Delgado explained that Mexico has established agreements for the pre-purchase of the candidate vaccines developed by the British laboratory AstraZeneca in conjunction with the University of Oxford; with the American pharmaceutical company Pfizer; with the Chinese company CanSino Biologics, and through the UN Covax protocol, which has nine candidates in phase three of clinical trials.
Only from the AstraZeneca and Pfizer candidate vaccines, Mexico has pre-purchased 163.3 million doses to immunize 63 percent of Mexicans, and would place it eighth in the table of countries with pre-purchase.
This is not counting the 35 million doses of CanSino. By covering 92 percent of its 127 million inhabitants, the country ranks fifth among those already with assured access to the drug.
The secretariat breaks down Mexico's pre-purchases of the different antidotes as follows: AstraZeneca, 77.4 million doses; Pfizer, 34.4 million; via Covax, 51.5 million; and CanSino, 35 million.
mh/abo/agp/lma/cvl
WEF stressed that each vaccine needs two doses to generate protection against the disease and added that only Canada, Japan, the United States and the United Kingdom would be the only governments capable of vaccinating more than 100 percent of their population.
Delgado explained that Mexico has established agreements for the pre-purchase of the candidate vaccines developed by the British laboratory AstraZeneca in conjunction with the University of Oxford; with the American pharmaceutical company Pfizer; with the Chinese company CanSino Biologics, and through the UN Covax protocol, which has nine candidates in phase three of clinical trials.
Only from the AstraZeneca and Pfizer candidate vaccines, Mexico has pre-purchased 163.3 million doses to immunize 63 percent of Mexicans, and would place it eighth in the table of countries with pre-purchase.
This is not counting the 35 million doses of CanSino. By covering 92 percent of its 127 million inhabitants, the country ranks fifth among those already with assured access to the drug.
The secretariat breaks down Mexico's pre-purchases of the different antidotes as follows: AstraZeneca, 77.4 million doses; Pfizer, 34.4 million; via Covax, 51.5 million; and CanSino, 35 million.
mh/abo/agp/lma/cvl
Temas Relacionados:
